Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing
Muhammad Waqar Ashraf,Satu Poikola,Mikko Neuvonen,Johanna I. Kiiski,Vesa K. Kontinen,Klaus T. Olkkola,Janne T. Backman,Mikko Niemi,Teijo I. Saari
DOI: https://doi.org/10.1007/s40262-024-01433-9
2024-10-24
Clinical Pharmacokinetics
Abstract:Codeine metabolism in humans is complex due to the involvement of multiple cytochrome P450 (CYP) enzymes, and has a strong genetic underpinning, which determines the levels of relevant CYP450 enzyme expression in vivo. Polymorphic CYP2D6 metabolises codeine to morphine via O-demethylation, while a strong correlation between CYP2D6 phenotype and opioidergic adverse effects of codeine is well documented. The aim of this study was to quantify the effect of CYP2D6 genotype on the biotransformation of codeine.
pharmacology & pharmacy
What problem does this paper attempt to address?